Cell Culture-Derived Tilapia Lake Virus-Inactivated Vaccine Containing Montanide Adjuvant Provides High Protection against Viral Challenge for Tilapia

Cell Culture-Derived Tilapia Lake Virus-Inactivated Vaccine Containing Montanide Adjuvant Provides High Protection against Viral Challenge for Tilapia

Tilapia lake virus (TiLV) is a newly emerging pathogen responsible for high mortality and economic losses in the global tilapia industry. Currently, no antiviral therapy or vaccines are available for the control of this disease. The goal of the present study was to evaluate the immunological effects...

Full description

Bibliographic Details
Main Authors: Weiwei Zeng, Yingying Wang, Huzi Hu, Qing Wang, Sven M. Bergmann, Yahui Wang, Bo Li, Yuefeng Lv, Hua Li, Jiyuan Yin, Yingying Li
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Vaccines
Subjects:
inactivated vaccine
tilapia lake virus
adjuvant
protection
Online Access:https://www.mdpi.com/2076-393X/9/2/86

Internet

https://www.mdpi.com/2076-393X/9/2/86

Similar Items